FABP4 and chronic obstructive pulmonary disease: The main results of this study show that, as hypothesized: (1) airway (but not plasma) levels of FABP4 are reduced in COPD patients, particularly in those with airway infection and more severe disease; and, (2) BALF FABP4 levels are related to the number and proportion of alveolar Mɸ.